172
Participants
Start Date
January 31, 2005
Primary Completion Date
April 30, 2009
Study Completion Date
October 31, 2009
Naltrexone
Drug: Naltrexone 12.5 mg oral capsule once per day for 1 day then 25 mg oral capsule once per day for 27 weeks
Transdermal nicotine replacement
Transdermal nicotine replacement (21 mg for first 6 weeks post-quit then 14 mg for 2 weeks) once per day + naltrexone 25 mg oral capsule once per day
Behavioral counseling
Brief behavioral counseling and research assessments are provided for two sessions prior to the quit date and then weekly for two weeks, bi-weekly for a month and every four weeks thereafter.
Yale University School of Medicine Substance Abuse Treatment Unit, New Haven
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH
Yale University
OTHER